Pulmonary drug delivery of quercetin through scalable PEGylated mixed micelles of Gelucire® and Tetronic®
Year: 2026
Type: article
Abstract: increased ROS generation and DNA damage, ultimately damaging cancer cells. Additionally, our findings support a practical and commercially viable approach for enhancing the solubility and therapeutic efficacy of hydrophobic drugs, which can be further useful in various biomedical applications, such as healthcare formulations and drug delivery.
Source: RSC Advances
DOI: 10.1039/d5ra09376g
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,042
Award: G165707928
OpenAlex ID: W7129451306
